Bassam Hallis

Public Health England - National Infection Service

United Kingdom

SCHOLARLY PAPERS

6

DOWNLOADS
Rank 946

SSRN RANKINGS

Top 946

in Total Papers Downloads

45,078

SSRN CITATIONS

6

CROSSREF CITATIONS

1

Scholarly Papers (6)

1.

Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine

Number of pages: 45 Posted: 25 Jun 2021
University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Public Health England Colindale, Government of the United Kingdom - Public Health Scotland, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of Liverpool - School of Tropical Medicine, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University Hospitals Birmingham NHS Foundation Trust, Public Health England - National Infection Service, University of London - Institute of Infection and Immunity, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Bristol - Bristol Vaccine Centre, University of Oxford - The Jenner Institute, Government of the United Kingdom - North Bristol NHS Trust, NIHR UCLH Clinical Research Facility, Public Health England - Immunisation, Hepatitis, and Blood Safety Department, University of Southampton - University Hospital Southampton NHS Foundation Trust, Nottingham University Hospitals NHS Trust, Imperial College London - National Heart & Lung Institute, University of Nottingham - Division of Epidemiology and Public Health, University of Oxford - Centre for Vaccinology and Tropical Medicine and Independent
Downloads 25,244 (181)
Citation 6

Abstract:

Loading...

2.

Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)

Number of pages: 40 Posted: 04 Feb 2021
University of Oxford - Oxford Vaccine Group, University of Oxford - Big Data Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Cambridge, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Cambridge - Department of Medicine, University of Oxford - Big Data Institute, University of Oxford - The Jenner Institute, Public Health England - National Infection Service, University of Oxford - Centre for Vaccinology and Tropical Medicine, Liverpool School of Tropical Medicine - Department of Clinical Sciences, UK Biocentre, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Oxford - Oxford Vaccine Group, University of Oxford - Jenner Institute, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, GSK plc, University of Oxford - The Jenner Institute, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Liverpool - School of Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Bristol - Bristol Vaccine Centre, University of Oxford - The Jenner Institute, University of Oxford - Jenner Institute, St George’s University London - St George’s Vaccine Institute, University College London - Department of Infection, University of Oxford - Clinical BioManufacturing Facility, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Oxford Vaccine Group, Public Health England - National Infection Service, University of London - Institute of Infection and Immunity, Queen Elizabeth University Hospital, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, NIHR UCLH Clinical Research Facility, Hull University Teaching Hospitals NHS Trust, Genomics England, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - The Jenner Institute, London Northwest University Healthcare, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Imperial College London - Department of Infectious Disease, University of Oxford - Oxford Vaccine Group, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, Western General Hospital - Clinical Infection Research Group, MRC-University of Glasgow Centre for Virus Research, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, Nottingham University Hospitals NHS Trust, AstraZeneca Biopharmaceuticals, AstraZeneca Pharmaceuticals, Anuerin Bevan University Health Board, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Independent and Independent
Downloads 10,805 (849)
Citation 26

Abstract:

Loading...

3.

Single Vaccination with BNT162b2 or ChAdOx1 in Older People Induces Equivalent Antibody Generation but Enhanced Cellular Responses after ChAdOx1

Number of pages: 15 Posted: 13 Apr 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Clinical Immunology Service, University Hospitals Birmingham NHS Foundation Trust, Harborne Medical Practice, Public Health England, Public Health England - Immunisation and Countermeasures Division, Public Health England - National Infection Service, University of Birmingham - Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 4,444 (3,871)
Citation 12

Abstract:

Loading...

Vaccination, SARS-CoV-2, COVID, Antibody, Cellular, mRNA, ChAdOx1

4.

The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)

Number of pages: 36 Posted: 30 Sep 2021
University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, University of Bristol, University Hospitals Bristol, Cardiff University - Centre for Trials Research, University of Bristol - Bristol Vaccine Centre, University Hospitals Bristol, Government of the United Kingdom - Royal United Hospitals Bath NHS Foundation Trust, Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - Royal United Hospitals Bath NHS Foundation Trust, Public Health England - National Infection Service, University of Bristol, University of Bristol, University of Bristol, University of Bristol, National Health Service, United Kingdom, NIHR UCLH Clinical Research Facility, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, University Hospitals Bristol - University Hospitals Bristol NHS Foundation Trust, Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - Great Western Hospitals, The Alverton Practice, University of Bristol, University of Bristol, University of Oxford - Centre for Vaccinology and Tropical Medicine, Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), University of Nottingham - Division of Epidemiology and Public Health, University of Bristol - Bristol Vaccine Centre, University of Bristol and Independent
Downloads 3,319 (6,343)

Abstract:

Loading...

Concomitant vaccination, COVID-19 vaccine, Influenza vaccine, Clinical Trial

5.

BNT162b2 Vaccination in People Over 80 Years of Age Induces Strong Humoral Immune Responses with Cross Neutralisation of P.1 Brazilian Variant

Number of pages: 24 Posted: 31 Mar 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Clinical Immunology Service, University of Birmingham - Institute of Immunology and Immunotherapy, Quinton and Harborne PCN, University of Birmingham - Institute of Immunology and Immunotherapy, Deparment of Buisness Energy and Industrial Strategy - Vaccine Taskforce, Public Health England, Public Health England - Immunisation and Countermeasures Division, Public Health England - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Public Health England, UK Health Security Agency - Rare & Imported Pathogens Laboratory, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Public Health England - National Infection Service, Oxford Immunotec LTD, University of Birmingham - Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 1,251 (28,869)

Abstract:

Loading...

Vaccination. SARS-CoV-2. COVID. Immunosenescence. Antibody. T-cell. Variant. Neutralisation. Ageing. Immunisation

6.

An Observational, Cohort, Multi-Centre, Open Label Phase IV Extension Study Comparing Preschool Dtap-Ipv Booster Vaccine Responses in Children Whose Mothers Were Randomised to One of Two Pertussis-Containing Vaccines or Received No Pertussis-Containing Vaccine in Pregnancy in England

Number of pages: 16 Posted: 12 Mar 2022
University of London, St. George's, Paediatric Infectious Diseases Research Group, Public Health England Colindale, Public Health England - National Infection Service, affiliation not provided to SSRN, University of Southampton, affiliation not provided to SSRN, London School of Hygiene & Tropical Medicine - Department of Infectious Disease and Epidemiology, University of Oxford - Centre for Vaccinology and Tropical Medicine and University of London - Institute of Infection and Immunity
Downloads 15 (931,240)

Abstract:

Loading...

maternal vaccination, immunisation, pertussis, immune, response, pregnancy, vaccine, blunting, children, booster